Back

Unraveling the choline pathway in heart failure risk and outcomes: a systematic review and meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Evolving approaches to diagnosing heart failure Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Arveen Shokravi

University of Calgary, Calgary (Canada)

5 More presentations in this session

Presentation thumbnail
National early warning score and clinical early warning score predict 1-year all-cause mortality among patients with acute heart failure
Doctor N. Olsen El Caidi (Hvidovre, DK)
Abstract Slides Video
Presentation thumbnail
Non-invasive diagnosis of heart failure with preserved ejection fraction with left atrioventricular coupling index
Ms C. Janssen Telders (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Machine learning-based heart sound and electrocardiogram analysis for detecting left ventricular dysfunction: a systematic review and diagnostic meta-analysis
Ms M. Ramos Miranda (BR)
Abstract Slides Video
Presentation thumbnail
Pentraxin-3 as a novel biomarker to monitor disease progress and treatment response in patients with heart failure
Miss L. Cao (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Coronary angiography versus coronary computed tomography angiography for coronary artery evaluation in patients with heart failure
Doctor B. Huang (Chongqing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Evolving approaches to diagnosing heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Betaine as a marker of hypervolemia in patients with HF
thumbnail
Congress Presentation
Circulating metabolites in patients with chronic heart failure are related to increased lipid utilisation but not to gut microbiota alterations
thumbnail
Congress Presentation
Interaction of gut microbiota-derived metabolites with inflammatory markers and cellular rejection in advanced heart failure patients treated with heart transplantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources